You are here

Vascular & Endovascular

 

Using virtual reality training to restore motor function after a stroke is just as effective as traditional physical therapy, reports a new study published in the medical journal Neurology.

The alternative smoking trend that’s taking over international markets might be more dangerous than tobacco companies are letting on—heat-not-burn tobacco’s negative impact on blood vessel function matches the damage done by smoking regular cigarettes, the American Heart Association reported at its Scientific Sessions 2017.

A simple, inexpensive tool could predict healthy individuals’ future risk of cardiovascular disease through just five painless calculations, Mount Sinai Health System reported today in a novel study. The paper was simultaneously published in the Journal of the American College of Cardiology.

Black men are most likely to suffer from intracranial atherosclerotic disease (ICAD), an important contributor to stroke, while midlife risk factors for the illness vary between blacks and whites, according to a new study published in JAMA Cardiology.

Five-minute interventions, “quit kits” and information delivered by peers all proved to be successful strategies for getting through to young smokers, research out of the University of California-Davis reports.

 

Recent Headlines

VR on par with traditional rehab in restoring motor function in stroke patients

Using virtual reality training to restore motor function after a stroke is just as effective as traditional physical therapy, reports a new study published in the medical journal Neurology.

Eating omega-3-enriched chicken provides similar health benefits as oily fish

Introducing omega-3 polyunsaturated fatty acids (PUFA) into chicken feed could provide a health benefit to humans at the top of the food chain, according to research presented Nov. 14 at the American Heart Association’s scientific sessions.

Smoking alternative marketed as safer than cigarettes minimizes blood vessel function by 60%

The alternative smoking trend that’s taking over international markets might be more dangerous than tobacco companies are letting on—heat-not-burn tobacco’s negative impact on blood vessel function matches the damage done by smoking regular cigarettes, the American Heart Association reported at its Scientific Sessions 2017.

New tool calculates cardiovascular risk in 5 painless steps

A simple, inexpensive tool could predict healthy individuals’ future risk of cardiovascular disease through just five painless calculations, Mount Sinai Health System reported today in a novel study. The paper was simultaneously published in the Journal of the American College of Cardiology.

Stroke predictor ICAD more prevalent in blacks than whites

Black men are most likely to suffer from intracranial atherosclerotic disease (ICAD), an important contributor to stroke, while midlife risk factors for the illness vary between blacks and whites, according to a new study published in JAMA Cardiology.

Peer-led interventions, "quit kits" prove successful quitting tools for young smokers

Five-minute interventions, “quit kits” and information delivered by peers all proved to be successful strategies for getting through to young smokers, research out of the University of California-Davis reports.

Efficacy of FPA in swine models could open the door for more accurate CAD testing in humans

A new lab technique could cut testing time and improve the accuracy of coronary artery disease (CAD) diagnoses, new research published in Radiology states.

Decreasing popularity of e-cigarettes could 'open the floodgates' for smoking alternative heat-not-burn tobacco

A smoking trend that’s taken over Japan could soon be making its debut in the American market, possibly eclipsing the infamous e-cigarette as a more authentic alternative to traditional tobacco products.

Hospitals frequently fail to perform follow-up imaging after vascular surgery

Nearly half of patients failed to receive follow-up imaging within a year of vascular surgery, even if their hospitals participated in a national quality improvement registry, according to an analysis of Medicare beneficiaries.

Lifesaving treatment administered to only 10% of eligible stroke patients

Two decades after being approved by the FDA for treatment of acute ischemic stroke, clot-dissolving medication intravenous alteplase is administered to just 10 percent of patients, researchers from Georgia State recently reported in the American Journal of Emergency Medicine.

Pages